Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Davis Chaim Create: Alert

All | News | Filings
Date FiledTypeDescription
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/10/2020 4 Davis Chaim (10% Owner) has filed a Form 4 on AMERICAN BIO MEDICA CORP
Txns: Granted 7,751 shares @ $0.21, valued at $1.6k
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/08/2020 5 Davis Chaim (10% Owner) has filed a Form 5 on AMERICAN BIO MEDICA CORP
01/08/2020 4 Davis Chaim (10% Owner) has filed a Form 4 on AMERICAN BIO MEDICA CORP
Txns: Granted 37,398 shares @ $0.09, valued at $3.4k
06/24/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/25/2019 4 Davis Chaim (Director) has filed a Form 4 on AMERICAN BIO MEDICA CORP
Txns: Granted 38,993 shares @ $0.08, valued at $3.1k
Bought 500,000 shares @ $0.1, valued at $50k
Acquired 50,000 options to buy @ $0.18, valued at $9k
10/09/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/27/2018 4 Davis Chaim (Director) has filed a Form 4 on AMERICAN BIO MEDICA CORP
Txns: Granted 33,784 shares @ $0.1, valued at $3.4k
Acquired 20,000 options to buy @ $0.1, valued at $2k
04/19/2018 3/A Davis Chaim (Director) has filed a Form 3/A on AMERICAN BIO MEDICA CORP
08/02/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
03/14/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
02/20/2013 4 Davis Chaim (Director) has filed a Form 4 on AtheroNova Inc.
Txns: Granted 25,000 options to buy @ $0.425, valued at $10.6k
06/29/2011 4 Davis Chaim (Director) has filed a Form 4 on AtheroNova Inc.
Txns: Granted 37,500 options to buy @ $1.01, valued at $37.9k
09/01/2010 4 Davis Chaim (Director) has filed a Form 4 on AtheroNova Inc.
Txns: Granted 75,000 options to buy @ $1.11, valued at $83.3k
05/24/2010 3 Davis Chaim (Director) has filed a Form 3 on AtheroNova, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy